() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Category Archives: Relevium Technologies

RELEVIUM SIGNS EXCLUSIVITY AGREEMENT WITH SOSCANNABIS.COM FOR REIMBURSEMENT FOR PEDIATRIC PATIENTS

July 10, 2019 - MONTREAL, QUEBEC – Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an exclusivity agreement to partner with SOS cannabis Inc. (“SOSCannabis”), which will provide pediatric customers with the ability to obtain free legal representation to seek reimbursement for the costs of medical cannabinoid therapy from different government agencies for the treatment of medical conditions for pediatric patients.
Read more

Relevium’s Biocannabix Positions Itself as an Important Player in Colombia as it Pursues Endo-Medical Cannabis Strategy for Latin America

Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”) announced today it is positioning itself as an important player in the Colombian medical cannabis market  by cementing medical and research relationships in the country in order to establish clinical validation programs for its Endo Nutraceutical Supplements (ENS) and Oral Nutritional Supplements.
Read more

Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST

June 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”), is pleased to announce it will be holding a shareholder and investor conference call to discuss its Latin American (LATAM) strategy and the upside potential of its recently announced acquisition in Colombia.
Read more

Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia

Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia MONTREAL, June 13, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that Biocannabix Health Corporation (“Biocannabix”), a wholly-owned subsidiary of Relevium has executed on June 12, 2019 a…
Read more
Get $50 in free trades.